Introduction Although it's benign nature, recurrent respiratory papillomatosis (RRP) has difficulties in medical cure due to its clinical symptoms and frequent recurrence. Laser ablation under laryngomicrosurgery has been the treatment of choice up to now, however, several other additional treatment modalities are attempted. On this study, cidofovir, a nucleoside analogue which inhibits the viral DNA replication, was injected intralesionally after primary excision of RRP using CO2 laser and/or pulsed dye laser (PDL), and its efficacy was evaluated. Method and Materials Thirtyseven patients of laryngeal papilloma from age of 4 to 68 were selected from July 2006 to August 2008, and after the lesion was removed using CO2 LASER or PDL, diluted ...
Cidofovir is an antiviral agent used in the therapy of recurrent respiratory papillomatosis (RRP). I...
Recurrent respiratory papillomatosis (RRP) is a chronic and difficult to treat disease of the larynx...
The efficacy of cidofovir in juvenile recurrent respiratory papillomatosis (JRRP) remains uncertain ...
Recurrent respiratory papillomatosis (RRP) is an uncommon disease that may cause symptoms ranging fr...
An 8-year-old patient with severe recurrent respiratory papil-lomatosis and pulmonary spread was tre...
Respiratory papillomatosis is a rare and often severe disease, usually localized in the larynx. It m...
Objectives: We performed a prospective, double-blind, placebo-controlled, longitudinal adjuvant ther...
Objectives: We performed a prospective, double-blind, placebo-controlled, longitudinal adjuvant ther...
BackgroundRecurrent laryngeal papillomatosis is caused by the human papilloma virus and characterize...
OBJECTIVE: To study the effect of local application of cidofovir in patients with recurrent laryngea...
Recurrent respiratory papillomatosis is a viral induced disease characterised by exophytic epithelia...
Recurrent respiratory papillomatosis is a viral-induced disease, associated with exophytic epithelia...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90089/1/phco.2005.25.7.977.pd
Recurrent respiratory papillomatosis is a viral-induced disease, associated with exophytic epithelia...
Recurrent respiratory papillomatosis is a viral induced disease characterised by exophytic epithelia...
Cidofovir is an antiviral agent used in the therapy of recurrent respiratory papillomatosis (RRP). I...
Recurrent respiratory papillomatosis (RRP) is a chronic and difficult to treat disease of the larynx...
The efficacy of cidofovir in juvenile recurrent respiratory papillomatosis (JRRP) remains uncertain ...
Recurrent respiratory papillomatosis (RRP) is an uncommon disease that may cause symptoms ranging fr...
An 8-year-old patient with severe recurrent respiratory papil-lomatosis and pulmonary spread was tre...
Respiratory papillomatosis is a rare and often severe disease, usually localized in the larynx. It m...
Objectives: We performed a prospective, double-blind, placebo-controlled, longitudinal adjuvant ther...
Objectives: We performed a prospective, double-blind, placebo-controlled, longitudinal adjuvant ther...
BackgroundRecurrent laryngeal papillomatosis is caused by the human papilloma virus and characterize...
OBJECTIVE: To study the effect of local application of cidofovir in patients with recurrent laryngea...
Recurrent respiratory papillomatosis is a viral induced disease characterised by exophytic epithelia...
Recurrent respiratory papillomatosis is a viral-induced disease, associated with exophytic epithelia...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90089/1/phco.2005.25.7.977.pd
Recurrent respiratory papillomatosis is a viral-induced disease, associated with exophytic epithelia...
Recurrent respiratory papillomatosis is a viral induced disease characterised by exophytic epithelia...
Cidofovir is an antiviral agent used in the therapy of recurrent respiratory papillomatosis (RRP). I...
Recurrent respiratory papillomatosis (RRP) is a chronic and difficult to treat disease of the larynx...
The efficacy of cidofovir in juvenile recurrent respiratory papillomatosis (JRRP) remains uncertain ...